Xinyue Chen

633 total citations
33 papers, 375 citations indexed

About

Xinyue Chen is a scholar working on Epidemiology, Hepatology and Immunology. According to data from OpenAlex, Xinyue Chen has authored 33 papers receiving a total of 375 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Epidemiology, 19 papers in Hepatology and 6 papers in Immunology. Recurrent topics in Xinyue Chen's work include Hepatitis B Virus Studies (20 papers), Hepatitis C virus research (19 papers) and Liver Disease Diagnosis and Treatment (6 papers). Xinyue Chen is often cited by papers focused on Hepatitis B Virus Studies (20 papers), Hepatitis C virus research (19 papers) and Liver Disease Diagnosis and Treatment (6 papers). Xinyue Chen collaborates with scholars based in China, United States and Australia. Xinyue Chen's co-authors include Lina Ma, Shan Ren, Junfeng Lu, Chengli Shen, Yali Liu, Xiaofei Du, Wenxiang Wang, Xue–Fan Bai, Yu‐Mei Wen and Limin Guo and has published in prestigious journals such as Blood, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Xinyue Chen

29 papers receiving 372 citations

Peers

Xinyue Chen

EPIDE

HEPAT

IMMUN

VIROL

Xiping Zhao China

M Sidorkiewicz Poland

Marianne Eisenhardt Germany

Edward M. Murray United States

Helen Cha United States

Andreia M. Serra Italy

Mathieu Lefèvre France

Gabriel Marceau Canada

Ilka Rebhan Germany

Xiping Zhao China

Xinyue Chen

263 ×1.0

EPIDE

260 ×1.1

HEPAT

86 ×0.9

IMMUN

55 ×1.5

37 ×1.1

VIROL

Citations per year, relative to Xinyue Chen Xinyue Chen (= 1×) peers Xiping Zhao

Countries citing papers authored by Xinyue Chen

Since Specialization

Citations

This map shows the geographic impact of Xinyue Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinyue Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinyue Chen more than expected).

Fields of papers citing papers by Xinyue Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xinyue Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinyue Chen. The network helps show where Xinyue Chen may publish in the future.

Co-authorship network of co-authors of Xinyue Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xinyue Chen. A scholar is included among the top collaborators of Xinyue Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xinyue Chen. Xinyue Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Xiaotong, Liang Sun, Xinyue Chen, et al.. (2025). The molecular mechanisms underlying retinal ganglion cell apoptosis and optic nerve regeneration in glaucoma (Review). International Journal of Molecular Medicine. 55(4). 5 indexed citations

Chen, Xinyue & Zhoumeng Lin. (2025). A Physiologically Based Pharmacokinetic Model of an Oral Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Adults. The Journal of Clinical Pharmacology. 65(8). 1011–1025.

Dong, Jianxia, Shan Ren, Ping Wu, et al.. (2025). Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon. Hepatology International. 19(6). 1331–1346.

Chen, Xinyue, et al.. (2024). Drug repurposing to tackle parainfluenza 3 based on multi-similarities and network proximity analysis. Frontiers in Pharmacology. 15. 1428925–1428925. 1 indexed citations

Zhao, Ping, Xinyue Chen, Wei Liu, et al.. (2024). Celastrol inhibits mouse B16-F10 melanoma cell survival by regulating the PI3K/AKT/mTOR signaling pathway and repressing HIF-1α expression. Discover Oncology. 15(1). 178–178. 7 indexed citations

Liu, Yisi, Shan Ren, Lina Ma, et al.. (2024). Peg-IFNα combined with hepatitis B vaccination contributes to HBsAg seroconversion and improved immune function. Virology Journal. 21(1). 77–77. 4 indexed citations

Liu, Yisi, Xiao Lin, Hong Li, et al.. (2023). Clinical study of hepatitis B vaccine in achieving hepatitis B surface antibody seroconversion in patients with functional cure. The Brazilian Journal of Infectious Diseases. 27(6). 103703–103703. 2 indexed citations

Liu, Yisi, Xiao Lin, Zhenhuan Cao, et al.. (2023). Analysis of clinical characteristics of thyroid disorders in patients with chronic hepatitis B treated with pegylated-interferon alpha. BMC Endocrine Disorders. 23(1). 115–115. 4 indexed citations

Li, Hong, Xiao Lin, Lili Liu, et al.. (2022). Low Level of Serum Immunoglobulin G Is Beneficial to Clinical Cure Obtained With Pegylated Interferon Therapy in Inactive Surface Antigen Carriers. Frontiers in Immunology. 13. 864354–864354. 2 indexed citations

10.

Lin, Xiao, Jingyue Wang, Xiaomo Wang, et al.. (2021). Cost-effectiveness of combination antiviral treatment with extended duration for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B in China. Annals of Translational Medicine. 9(17). 1365–1365. 6 indexed citations

11.

Shen, Chengli, et al.. (2019). Antiviral treatment for chronic hepatitis B: Safety, effectiveness, and prognosis. World Journal of Clinical Cases. 7(14). 1784–1794. 12 indexed citations

12.

Chen, Xinyue, Xiaoguang Dou, Qing Xie, et al.. (2019). A Potential Functional Cure in Chinese HBeAg-negative Chronic Hepatitis B Patients Treated with Peg-interferon Alpha-2a. Journal of Clinical and Translational Hepatology. 7(X). 1–9. 6 indexed citations

13.

Zhang, Wenhong, Dazhi Zhang, Xiaoguang Dou, et al.. (2018). Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B. Journal of Clinical and Translational Hepatology. 6(1). 1–10. 20 indexed citations

14.

Jiao, Yanmei, Ning Li, Xinyue Chen, et al.. (2014). Acute HIV Infection Is Beneficial for Controlling Chronic Hepatitis B. Clinical Infectious Diseases. 60(1). 128–134. 7 indexed citations

15.

Ren, Shan, Junfeng Lu, Xiaofei Du, et al.. (2012). Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma. Cancer Immunology Immunotherapy. 61(9). 1433–1439. 39 indexed citations

16.

Zhang, Yonghong, et al.. (2010). The immune response during acute HIV-1 infection. 37(4). 265–269. 1 indexed citations

17.

Shi, Ying, Yali Liu, Junfeng Li, et al.. (2010). Keratin 18 phosphorylation as a progression marker of chronic hepatitis B. Virology Journal. 7(1). 70–70. 10 indexed citations

18.

Zheng, Linghua, Dongling Li, Fu‐Sheng Wang, et al.. (2010). Association Between Hepatitis B Viral Burden in Chronic Infection and a Functional Single Nucleotide Polymorphism of the PDCD1 Gene. Journal of Clinical Immunology. 30(6). 855–860. 18 indexed citations

19.

Chen, Yue, Chengli Shen, Hao Wu, et al.. (2008). Biological properties of HIV-1 subtype B' isolates from infected Chinese blood donors at different disease stages. Virology. 384(1). 161–168. 3 indexed citations

20.

Li, Haiying, Xiaojie Huang, Caiping Guo, et al.. (2008). Heightened T-cell proliferation without an elevation of CD4+ T cell spontaneous apoptosis in AIDS patients. Clinical Immunology. 129(3). 499–508.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact